Skip to main content
SpringerLink
Log in

Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population

  • Research Article
  • Published:
Tumor Biology

Abstract

Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene are considered to have some influence on both folate metabolism and cancer risk. Previous studies on the associations of MTHFR genetic polymorphisms with hepatocellular carcinoma (HCC) risk in Chinese population reported inconsistent results. We performed this meta-analysis to comprehensively assess the associations. Finally, 12 individual case–control studies were included into the meta-analysis. There were seven studies (6,384 subjects) on the MTHFR C677T polymorphism and five studies (4,502 subjects) on the MTHFR A1298C polymorphism. Overall, MTHFR C677T polymorphism was significantly associated with susceptibility to HCC in Chinese population (T versus C, odds ratio (OR) = 1.09, 95 % confidence interval (95 % CI) 1.01–1.17; TT versus CC, OR = 1.17, 95 % CI 1.00–1.38; TT/CT versus CC, OR = 1.12, 95 % CI 1.00–1.26). MTHFR A1298C polymorphism was conversely associated with HCC risk in Chinese population (CC versus AA, OR = 0.65, 95 % CI 0.46–0.91; CC versus AA/AC, OR = 0.64, 95 % CI 0.46–0.90). The sensitivity analysis confirmed the reliability and stability of the meta-analysis. Thus, the findings from our meta-analysis support the associations of MTHFR C677T and A1298C polymorphisms with HCC risk in Chinese population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245–55.

    Article  PubMed  Google Scholar 

  2. Bridges JF, Joy SM, Gallego G, Kudo M, Ye SL, Han KH, et al. Needs for hepatocellular carcinoma control policy in the Asia-Pacific region. Asian Pac J Cancer Prev. 2011;12:2585–91.

    PubMed  Google Scholar 

  3. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264–1273e1.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Yu MC, Yuan JM, Lu SC. Alcohol, cofactors and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23 Suppl 1:S92–97.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  5. Fodinger M, Horl WH, Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol. 2000;13:20–33.

    PubMed  CAS  Google Scholar 

  6. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA. 2008;299:2423–36.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet. 1998;62:1258–60.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet. 1994;7:195–200.

    Article  PubMed  CAS  Google Scholar 

  9. Kim YI. Role of the MTHFR polymorphisms in cancer risk modification and treatment. Future Oncol. 2009;5:523–42.

    Article  PubMed  CAS  Google Scholar 

  10. Izmirli M. A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk. Mol Biol Rep. 2013;40:625–37.

    Article  PubMed  CAS  Google Scholar 

  11. Zhu ZZ, Cong WM, Liu SF, Xian ZH. Wu WQ: [A study on the association of MTHFR c677T polymorphism with genetic susceptibility to hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi. 2006;14:196–8.

    PubMed  Google Scholar 

  12. Mu LN, Cao W, Zhang ZF, Cai L, Jiang QW, You NC, et al. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Causes Control. 2007;18:665–75.

    Article  PubMed  Google Scholar 

  13. Yuan JM, Lu SC, Van Den Berg D, Govindarajan S, Zhang ZQ, Mato JM, et al. Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Hepatology. 2007;46:749–58.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  14. An Y, Jin L, Chen J. Folate metabolic network gene polymorphism and primary liver cancer genetic susceptibility. Wanfang Doctoral Dissertation. 2008;2008:2008.

    Google Scholar 

  15. Liu J, Gao Y, Du Z, Yang B, Jing X, Wang Y. Relationship between the MTHFR C677T polymorphism and the outcome of hepatitis B virus infection. World Chinese Journal of Digestology. 2010;18:1555–62.

    CAS  Google Scholar 

  16. Cui LH, Song Y, Si H, Shen F, Shin MH, Kim HN, et al. Folate metabolism-related gene polymorphisms and susceptibility to primary liver cancer in North China. Med Oncol. 2012;29:1837–42.

    Article  PubMed  CAS  Google Scholar 

  17. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.

    Article  Google Scholar 

  18. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    PubMed  CAS  Google Scholar 

  20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  PubMed  CAS  Google Scholar 

  21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  22. Yang H, He F, Zhou G. Genetic association studies on candidate genes for chronic hepatitis B, liver and nasopharyngeal cancers. Wanfang Doctoral Dissertation. 2007;2007:2007.

    Google Scholar 

  23. Yu L, Chen J. Association of MTHFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: an update meta-analysis based on 51 research studies. Diagn Pathol. 2012;7:171.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  24. Zhong S, Yang JH, Liu K, Jiao BH, Chang ZJ. Quantitative assessment of the association between MTHFR C677T polymorphism and colorectal cancer risk in East Asians. Tumour Biol. 2012;33:2041–51.

    Article  PubMed  CAS  Google Scholar 

  25. Mei Q, Zhou D, Gao J, Shen S, Wu J, Guo L, et al. The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis. BMC Cancer. 2012;12:467.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of General Surgery, The First People’s Hospital of Shanghai, Shanghai, 200080, China

    Xiaosheng Qi, Xing Sun, Junming Xu, Zhaowen Wang, Jinyan Zhang & Zhihai Peng

Authors
  1. Xiaosheng Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xing Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junming Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhaowen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jinyan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhihai Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhihai Peng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qi, X., Sun, X., Xu, J. et al. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population. Tumor Biol. 35, 1757–1762 (2014). https://doi.org/10.1007/s13277-013-1529-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1529-x

Keywords

Search

Navigation